Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a minor release/version change without affecting the study details shown.
    Difference
    0.0%
    Check dated 2026-04-24T16:41:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:26:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision bumped from v3.4.3 to v3.5.0. This appears to be an internal site update with no visible changes to the study details or related content.
    Difference
    0.0%
    Check dated 2026-03-19T19:19:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. This appears to be a version bump with no visible changes to page content.
    Difference
    0.0%
    Check dated 2026-03-12T14:57:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the Notice about government funding lapse and the prior Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T20:26:22.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government funding notice about data currency and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:50:13.000Z thumbnail image

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.